View Older Stories View More Recent Stories

Apr 20, 2021 12:01PM Deerfield Management Announces Winners of the First Annual XSeed Award
Apr 14, 2021 04:05PM Lumos Pharma to Host Key Opinion Leader Event on LUM-201 for the Treatment of Pediatric Growth Hormone Deficiency
Apr 14, 2021 04:05PM Lumos Pharma to Host Key Opinion Leader Event on LUM-201 for the Treatment of Pediatric Growth Hormone Deficiency
Apr 13, 2021 08:00AM Endologix LLC Announces Acquisition of PQ Bypass, Inc.
Apr 13, 2021 08:00AM Jaguar Gene Therapy Closes $139 Million Series B Funding Co-led by Eli Lilly and Company and Deerfield Management
Apr 13, 2021 06:30AM Less Than a Year After Official Company Launch, Cohere Health Lands Additional $36 Million in Series B Funding
Apr 12, 2021 02:27PM GH Research Announces Closing of $125 Million Oversubscribed Series B Financing
Apr 6, 2021 11:30AM Vesta Healthcare Announces $65M in Growth Capital to Transform Care for High Needs Members and their Caregivers
Apr 6, 2021 08:00AM New Report Authored by Deerfield Management Reveals Vast Gender Gap Across Venture-backed Healthcare Companies
Apr 5, 2021 08:00AM Dracen Announces DRP-104 (sirpiglenastat) Presentations at AACR Virtual Annual Meeting
Mar 31, 2021 08:00AM Deerfield Management, UNC Eshelman School of Pharmacy Announce First Educational Collaboration
Mar 30, 2021 04:05PM Terns Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
Mar 29, 2021 07:30AM Crossover Health Secures $168 Million in Series D Financing to Fuel Expansion of National Primary Health Service
Mar 23, 2021 07:00AM Nuvalent Appoints Christopher Turner, M.D., as Chief Medical Officer
Mar 22, 2021 07:00AM Blade Therapeutics Announces Appointment of Jean-Frédéric Viret as Chief Financial Officer
Mar 20, 2021 11:00AM Data Presented at ENDO 2021 Differentiate LUM-201 from Standard Growth Hormone Secretagogues and Further Support LUM-201’s Potential as a Therapeutic for Pediatric Growth Hormone Deficiency
Mar 20, 2021 11:00AM Data Presented at ENDO 2021 Differentiate LUM-201 from Standard Growth Hormone Secretagogues and Further Support LUM-201’s Potential as a Therapeutic for Pediatric Growth Hormone Deficiency
Mar 17, 2021 09:00AM Happify Health Raises $73M to Advance and Expand Digital Health Platform
Mar 17, 2021 09:00AM Happify Health Raises $73M to Advance and Expand Digital Health Platform
Mar 16, 2021 03:25PM Lumos Pharma Inc. (NASDAQ: LUMO) Featured in Virtual Coverage of the 33rd Annual ROTH Conference
Mar 15, 2021 07:30AM Graphite Bio Secures $150 Million Series B Financing to Advance Pipeline of Next-Generation Gene Editing Therapies
Mar 11, 2021 05:15PM Nuvation Bio Reports Full Year 2020 Financial Results and Provides Business Update
Mar 11, 2021 04:05PM Lumos Pharma to Participate in March 2021 Investor Conferences
Mar 11, 2021 04:05PM Lumos Pharma to Participate in March 2021 Investor Conferences
Mar 11, 2021 07:07AM Xeris Pharmaceuticals (XERS) Prices $27 Million Registered Direct Offering of Common Stock at $4.12/sh
Mar 11, 2021 07:00AM Xeris Pharmaceuticals Announces Pricing of $27.0 Million Registered Direct Offering
Mar 9, 2021 04:05PM Lumos Pharma Reports Full Year 2020 Financial Results and Provides Update on OraGrowtH Trials in PGHD
Mar 9, 2021 04:05PM Lumos Pharma Reports Full Year 2020 Financial Results and Provides Update on OraGrowtH Trials in PGHD
Mar 9, 2021 08:00AM Coridea and Deerfield to Accelerate Medtech Innovation
Mar 8, 2021 08:01AM Dracen Announces Clinical Collaboration with Merck
Mar 4, 2021 09:05AM Lumos Pharma (LUMO) Says Data Supporting Use of Predictive Enrichment Markers for its LUM-201 Therapy in Clinical Trials for Moderate PGHD Published in Journal of the Endocrine Society
Mar 4, 2021 09:00AM Data Supporting Use of Predictive Enrichment Markers for Lumos Pharma’s LUM-201 Therapy in Clinical Trials for Moderate PGHD Published in Journal of the Endocrine Society
Mar 4, 2021 09:00AM Data Supporting Use of Predictive Enrichment Markers for Lumos Pharma’s LUM-201 Therapy in Clinical Trials for Moderate PGHD Published in Journal of the Endocrine Society
Mar 3, 2021 09:00AM Empire BlueCross BlueShield Partners with On-Demand Healthcare Service Ready to Provide New York City Residents Medical Care in Their Homes
Mar 2, 2021 04:05PM Lumos Pharma to Present Poster Demonstrating Greater GH Response to LUM-201 than to Standard GH Secretagogues in PGHD at the Endocrine Society (ENDO) 2021 Annual Meeting
Mar 2, 2021 04:05PM Lumos Pharma to Present Poster Demonstrating Greater GH Response to LUM-201 than to Standard GH Secretagogues in PGHD at the Endocrine Society (ENDO) 2021 Annual Meeting
Mar 1, 2021 07:00AM FogPharma® Announces $107 Million Series C Financing to Advance Direct β-Catenin Antagonist and Universal Druggability™ Platform
Feb 25, 2021 07:00AM Jaguar Gene Therapy Launches with Mission to Accelerate Breakthroughs in Gene Therapy for Patients Suffering from Severe Genetic Diseases
Feb 25, 2021 07:00AM Renowned Geneticist Philip Beales Launches Axovia Therapeutics to Develop Transformative Medicines for Ciliopathies
Feb 25, 2021 07:00AM Renowned Geneticist Philip Beales Launches Axovia Therapeutics to Develop Transformative Medicines for Ciliopathies
Feb 25, 2021 01:00AM Valneva Reports FY 2020 Results and Major Corporate Achievements
Feb 25, 2021 01:00AM Valneva Reports FY 2020 Results and Major Corporate Achievements
Feb 24, 2021 09:00AM Independence Blue Cross and Quartet Health Collaborate to Address Behavioral Health
Feb 24, 2021 06:00AM Xilio Therapeutics Raises $95 Million in Series C Financing to Advance Potent Tumor-Selective Immuno-Oncology Pipeline
Feb 22, 2021 04:15PM Lumos Pharma to Report Full Year 2020 Financial Results and Host Conference Call on March 9, 2021
Feb 22, 2021 04:15PM Lumos Pharma to Report Full Year 2020 Financial Results and Host Conference Call on March 9, 2021
Feb 16, 2021 04:38PM Form 13F-HR DEERFIELD MANAGEMENT For: Dec 31
Feb 16, 2021 04:01PM Lumos Pharma Announces Changes to its Board of Directors
Feb 16, 2021 04:01PM Lumos Pharma Announces Changes to its Board of Directors
Feb 10, 2021 04:05PM Nuvation Bio Closes Transaction with Panacea, Debuts as Publicly Traded Oncology Company
View More Recent Stories View Older Stories